March 2024
1. TAILOR TD, Christensen JD
   Beyond the AJR: Potential Role for Opportunistic Lung Cancer Screening.
   AJR Am J Roentgenol. 2024 Mar 13. doi: 10.2214/AJR.24.31039.
   

   >> Share

   
   
2. PARK C, Lee BC, Jeong WG, Park WJ, et al
   Coronary Artery Calcification on Low-Dose Lung Cancer Screening CT in South Korea: Visual and Artificial Intelligence-Based Assessment and Association With Cardiovascular Events.
   AJR Am J Roentgenol. 2024 Mar 6. doi: 10.2214/AJR.24.30852.
   

   >> Share

   
   February 2024
3. PARK J, Lee JH, Hong W, Hwang EJ, et al
   Usual Interstitial Pneumonia: Associations With Complications After Percutaneous Transthoracic Needle Lung Biopsy.
   AJR Am J Roentgenol. 2024;222:e2329938.
   

   >> Share

   
   November 2023
4. ALY AK
   Editorial Comment: Percutaneous Ablation of Early-Stage Non-Small Cell Lung Cancer Has Reasonable Safety Profile in Patients With Interstitial Lung Disease.
   AJR Am J Roentgenol. 2023 Nov 29. doi: 10.2214/AJR.23.30579.
   

   >> Share

   
   
5. HARDIE RC, Trout AT, Dillman JR, Narayanan BN, et al
   Performance Analysis in Children of Traditional and Deep-Learning CT Lung Nodule Computer-Aided Detection Systems Trained on Adults.
   AJR Am J Roentgenol. 2023 Nov 22. doi: 10.2214/AJR.23.30345.
   

   >> Share

   
   
6. FINTELMANN FJ, Graur A, Oueidat K, Simon J, et al
   Ablation of Stage I-II Non-Small Cell Lung Cancer in Patients With Interstitial Lung Disease: A Multicenter Retrospective Study.
   AJR Am J Roentgenol. 2023 Nov 15. doi: 10.2214/AJR.23.30300.
   

   >> Share

   
   August 2023
7. USUZAKI T
   Editorial Comment: Implementing an End-to-End Deep Learning Model in the Task of Differentiating Pure Ground-Glass Nodules on Chest CT.
   AJR Am J Roentgenol. 2023 Aug 2. doi: 10.2214/AJR.23.30002.
   

   >> Share

   
   July 2023
8. QI K, Wang K, Wang X, Zhang Y, et al
   Lung-PNet: An Automated Deep Learning Model for the Diagnosis of Invasive Adenocarcinoma in Pure Ground-Glass Nodules on Chest CT.
   AJR Am J Roentgenol. 2023 Jul 26. doi: 10.2214/AJR.23.29674.
   

   >> Share

   
   
9. MENDOZA D
   Editorial Comment: Reticulation Sign-Looking Through the Ground-Glass Nodule.
   AJR Am J Roentgenol. 2023;221:79.
   

   >> Share

   
   June 2023
10. HAVER HL, Lin CT, Sirajuddin A, Yi PH, et al
    Use of ChatGPT, GPT-4, and Bard to Improve Readability of ChatGPT's Answers to Common Questions on Lung Cancer and Lung Cancer Screening.
    AJR Am J Roentgenol. 2023 Jun 21. doi: 10.2214/AJR.23.29622.
    

    >> Share

    
    
11. GOO JM
    Editorial Comment: Prognostic Implications of CT-Defined Extranodal Extension of Metastatic Lymph Nodes in Patients with Non-Small Cell Lung Cancer.
    AJR Am J Roentgenol. 2023 Jun 7. doi: 10.2214/AJR.23.29724.
    

    >> Share

    
    May 2023
12. JANG S, Lee S, Chung JH, Lee KW, et al
    Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non-Small Cell Lung Cancer: Prognostic Utility and Diagnostic Performance.
    AJR Am J Roentgenol. 2023 May 31. doi: 10.2214/AJR.23.29285.
    

    >> Share

    
    April 2023
13. LIANG ZR, Lv FJ, Fu BJ, Lin RY, et al
    Reticulation Sign on Thin-Section CT: Utility for Predicting Invasiveness of Pure Ground-Glass Nodules.
    AJR Am J Roentgenol. 2023 Apr 20:1-10. doi: 10.2214/AJR.22.28892.
    

    >> Share

    
    
14. MURPHY DJ, Mayoral M, Larici AR, Ginsberg MS, et al
    Imaging Follow-Up of Nonsurgical Therapies for Lung Cancer: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2023 Apr 5. doi: 10.2214/AJR.23.29104.
    

    >> Share

    
    March 2023
15. BERGMANN LL
    Editorial Comment: Multichannel Outreach for Lung Cancer Screening Adoption.
    AJR Am J Roentgenol. 2023 Mar 29. doi: 10.2214/AJR.23.29354.
    

    >> Share

    
    
16. ZIPPI ZD, Cortopassi IO, Johnson EM, McDermott S, et al
    U.S. Newspaper Coverage of Lung Cancer Screening from 2010 to 2022.
    AJR Am J Roentgenol. 2023 Mar 15. doi: 10.2214/AJR.23.29066.
    

    >> Share

    
    
17. CASTANER E, Escalon JG, Herold CJ, Wan YL, et al
    The Global Reading Room: Incidental Lung Nodules on Abdominopelvic CT.
    AJR Am J Roentgenol. 2023 Mar 8. doi: 10.2214/AJR.23.29220.
    

    >> Share

    
    
18. NAIR A, Dyer DS, Heuvelmans MA, Mashar M, et al
    Contextualizing the Role of Volumetric Analysis in Pulmonary Nodule Assessment: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2023;220:314-329.
    

    >> Share

    
    February 2023
19. HOCHHEGGER B, Braithwaite D
    Beyond the AJR: Should Imaging-Based Risk Assessment Tools Be Used in Lung Cancer Screening?
    AJR Am J Roentgenol. 2023 Feb 1. doi: 10.2214/AJR.23.29060.
    

    >> Share

    
    
20. LEE GM
    Editorial Comment: Advances in Dual-Energy CT Utilization in Cancer Imaging in the Chest.
    AJR Am J Roentgenol. 2023 Feb 1. doi: 10.2214/AJR.23.29018.
    

    >> Share

    
    January 2023
21. SATO Y, Ishiyama M, Nakano S, Nakao M, et al
    Ringlike Peripheral Increased Iodine Concentration for the Differentiation of Primary Lung Cancer and Pulmonary Metastases on Contrast-Enhanced Dual-Energy CT.
    AJR Am J Roentgenol. 2023 Jan 11. doi: 10.2214/AJR.22.28654.
    

    >> Share

    
    November 2022
22. ZAGUROVSKAYA M
    Editorial Comment: Lung Function Patterns Present Global and Regional Similarities and Differences After Lobectomy and Limited Resection on Dual-Energy CT Assessment.
    AJR Am J Roentgenol. 2022 Nov 30. doi: 10.2214/AJR.22.28746.
    

    >> Share

    
    
23. OPTICAN RJ, Chiles C
    Lung Cancer Screening in Never Smokers: Counterpoint-Cannot Identify Which Never Smokers Are at Sufficient Risk to Balance the Potential Harms of Screening.
    AJR Am J Roentgenol. 2022 Nov 2. doi: 10.2214/AJR.22.28644.
    

    >> Share

    
    
24. KANNE JP
    Lung Cancer Screening in Never Smokers: Point-Might Reduce Mortality With Comprehensive Risk Assessment and Conservative Nodule Management.
    AJR Am J Roentgenol. 2022 Nov 2. doi: 10.2214/AJR.22.28627.
    

    >> Share

    
    
25. SUH YJ, Lee CY, Lee S, Kim HE, et al
    Patterns of Postoperative Changes in Lung Volume and Perfusion Assessed by Dual-Energy CT: Comparison of Lobectomy and Limited Resection.
    AJR Am J Roentgenol. 2022 Nov 2. doi: 10.2214/AJR.22.28450.
    

    >> Share

    
    
26. GOH V
    Editorial Comment: Artificial Intelligence for Lung Nodules-Progress, but Is It Enough?
    AJR Am J Roentgenol. 2022;219:712.
    

    >> Share

    
    
27. LIU JA, Yang IY, Tsai EB
    Artificial Intelligence (AI) for Lung Nodules, From the AJR Special Series on AI Applications.
    AJR Am J Roentgenol. 2022;219:703-712.
    

    >> Share

    
    September 2022
28. HALPENNY D
    Editorial Comment: Improving Lung Screening Specificity-Is There a Need to Use Nodule Volumetrics and Broaden Definitions of Intrapulmonary Lymph Nodes?
    AJR Am J Roentgenol. 2022;219:406.
    

    >> Share

    
    
29. HAMMER MM, Hunsaker AR
    Strategies for Reducing False-Positive Screening Results for Intermediate-Size Nodules Evaluated Using Lung-RADS: A Secondary Analysis of National Lung Screening Trial Data.
    AJR Am J Roentgenol. 2022;219:397-405.
    

    >> Share

    
    August 2022
30. TAFFEL M, Petrocelli RD, Rigau D, Schieda N, et al
    Prevalence of Malignancy in Adrenal Nodules with Heterogeneous Microscopic Fat on Chemical-Shift MRI: A Multiinstitutional Study.
    AJR Am J Roentgenol. 2022 Aug 3. doi: 10.2214/AJR.22.27976.
    

    >> Share

    
    July 2022
31. ELICKER BM
    Editorial Comment: Stability of Screen-Detected Lung Cancers on Serial CT Examinations.
    AJR Am J Roentgenol. 2022 Jul 6. doi: 10.2214/AJR.22.28179.
    

    >> Share

    
    
32. TERRY NLJ
    Editorial Comment: Lung-RADS-Looking Back to Move Forward.
    AJR Am J Roentgenol. 2022;219:65.
    

    >> Share

    
    June 2022
33. BYRNE SC, Hammer MM
    Malignant Nodules Detected on Lung Cancer Screening CT: Yield of Short-Term Follow-Up CT in Demonstrating Nodule Growth.
    AJR Am J Roentgenol. 2022 Jun 8. doi: 10.2214/AJR.22.27869.
    

    >> Share

    
    May 2022
34. BERGMANN LL, Hobbs S
    Beyond the AJR: The Impact of Screening Population in Lung Cancer Overdiagnosis.
    AJR Am J Roentgenol. 2022 May 25. doi: 10.2214/AJR.22.27970.
    

    >> Share

    
    
35. GIERADA DS, Pinsky PF
    Beyond the AJR: Larger and More Diverse Lung Cancer Screening Population Expected After Expansion of Recommended Eligibility Criteria by U.S. Preventive Services Task Force.
    AJR Am J Roentgenol. 2022 May 4:1. doi: 10.2214/AJR.21.27288.
    

    >> Share

    
    
36. VANDERLAAN PA
    Percutaneous Lung Biopsy: Point-Fine-Needle Aspiration First.
    AJR Am J Roentgenol. 2022;218:794-795.
    

    >> Share

    
    
37. ALEXANDER ES, Ziv E
    Percutaneous Lung Biopsy: Counterpoint-Core Biopsy to Allow for Molecular and Histologic Subtyping.
    AJR Am J Roentgenol. 2022;218:796.
    

    >> Share

    
    April 2022
38. TAHIR I, Marquardt JP, Mercaldo ND, Bourgouin PP, et al
    Utility of Noncancerous Chest CT Features for Predicting Overall Survival and Noncancer Death in Patients With Stage I Lung Cancer Treated With Stereotactic Body Radiotherapy.
    AJR Am J Roentgenol. 2022 Apr 13. doi: 10.2214/AJR.22.27484.
    

    >> Share

    
    
39. CHILES C, Osarogiagbon RU
    Beyond the AJR: To Expand the Population-Level Benefit of Lung Cancer Screening, Expand Access to Racially Diverse Populations.
    AJR Am J Roentgenol. 2022 Apr 6:1. doi: 10.2214/AJR.21.27032.
    

    >> Share

    
    
40. SUNDARAM B
    Editorial Comment: Promising Role of Volume Doubling Time in Patients With Sarcoma Lung Metastasis.
    AJR Am J Roentgenol. 2022;218:633.
    

    >> Share

    
    March 2022
41. MURPHY MC, Wrobel MM, Fisher DA, Cahalane AM, et al
    Update on Image-Guided Thermal Lung Ablation: Society Guidelines, Therapeutic Alternatives, and Postablation Imaging Findings.
    AJR Am J Roentgenol. 2022 Mar 23. doi: 10.2214/AJR.21.27099.
    

    >> Share

    
    
42. SANDLER KL, Deppen SA
    Beyond the AJR: Disparities in Lung Cancer Screening Adherence Persist in the Veterans Health Administration.
    AJR Am J Roentgenol. 2022 Mar 2:1. doi: 10.2214/AJR.21.26852.
    

    >> Share

    
    
43. BOURGOUIN PP, Wrobel MM, Mercaldo ND, Murphy MC, et al
    Comparison of Percutaneous Image-Guided Microwave Ablation and Cryoablation for Sarcoma Lung Metastases: A 10-Year Experience.
    AJR Am J Roentgenol. 2022;218:494-504.
    

    >> Share

    
    February 2022
44. ZAFAR N
    Utility of Flat-Bevel Tip Introducer Cannula for Local Pleural Anesthesia During Percutaneous CT-Guided Lung Biopsy.
    AJR Am J Roentgenol. 2022 Feb 2. doi: 10.2214/AJR.21.27306.
    

    >> Share

    
    January 2022
45. MENDOZA DP, Petranovic M, Som A, Wu MY, et al
    Lung-RADS Category 3 and 4 Nodules on Lung Cancer Screening in Clinical Practice.
    AJR Am J Roentgenol. 2022 Jan 26. doi: 10.2214/AJR.21.27180.
    

    >> Share

    
    
46. BENNETT P
    Editorial Comment: Evolving Indications for FDG PET/MRI in Lung Cancer.
    AJR Am J Roentgenol. 2022 Jan 5. doi: 10.2214/AJR.21.27246.
    

    >> Share

    
    December 2021
47. LICHTENBERGER JP 3RD
    Reporting of Clinical Stage for Lung Cancer: Point-Yes, Report an Overall TNM Stage.
    AJR Am J Roentgenol. 2021 Dec 15. doi: 10.2214/AJR.21.27203.
    

    >> Share

    
    
48. PEREZ-JOHNSTON R, McDermott S
    Reporting of Clinical Stage For Lung Cancer: Counterpoint-We Are Not There Yet!
    AJR Am J Roentgenol. 2021 Dec 15. doi: 10.2214/AJR.21.27188.
    

    >> Share

    
    
49. OHNO Y, Yoshikawa T, Takenaka D, Koyama H, et al
    Small Cell Lung Cancer Staging: Prospective Comparison of Conventional Staging Tests, FDG PET/CT, Whole-Body MRI, and Coregistered FDG PET/MRI.
    AJR Am J Roentgenol. 2021 Dec 8. doi: 10.2214/AJR.21.26868.
    

    >> Share

    
    November 2021
50. HAMMER MM, Byrne SC
    Cancer Risk in Nodules Detected at Follow-up Lung Cancer Screening CT.
    AJR Am J Roentgenol. 2021 Nov 10. doi: 10.2214/AJR.21.26927.
    

    >> Share

    
    
51. AHN Y, Lee SM, Kim MS, Choi S, et al
    Volume Doubling Times of Pulmonary Metastases in Patients With Bone and Soft Tissue Sarcomas: Associations With Subsequent New Metastases and Survival After Metastasectomy.
    AJR Am J Roentgenol. 2021 Nov 3. doi: 10.2214/AJR.21.26859.
    

    >> Share

    
    
52. WROBEL MM, Bourgouin PP, Kashani MA, Leppelmann KS, et al
    Active Versus Passive Thaw After Percutaneous Cryoablation of Pulmonary Tumors: Effect on Incidence, Grade, and Onset of Hemoptysis.
    AJR Am J Roentgenol. 2021;217:1153-1163.
    

    >> Share

    
    October 2021
53. ELICKER BM, Kallianos KG
    Biopsy of Subsolid Nodules Suspicious for Adenocarcinoma: Counterpoint-Biopsy Has Limited Utility in the Diagnostic Evaluation of Subsolid Nodules.
    AJR Am J Roentgenol. 2021;217:815-816.
    

    >> Share

    
    
54. HEALEY TT, Shepard JO
    Biopsy of Subsolid Nodules Suspicious for Adenocarcinoma: Point-CT-Guided Biopsy of Subsolid Nodules Is a Safe and Effective Means to Establish a Definitive Preoperative Diagnosis.
    AJR Am J Roentgenol. 2021;217:813-814.
    

    >> Share

    
    August 2021
55. BARUAH D
    Editorial Comment: Diagnosing Mediastinal Lymph Node Involvement in Non Small Cell Lung Cancer Noninvasively With Advanced Imaging Markers-Are We There Yet?
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.26661.
    

    >> Share

    
    
56. STEFANIDIS K, Konstantelloy E, Yusuf G, Moser J, et al
    The Evolving Landscape of Lung Cancer Surgical Resection: An Update for Radiologists With Focus on Key Chest CT Findings.
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.26408.
    

    >> Share

    
    
57. PARK R, Lee SM, Kim S, Park S, et al
    Learning Curve for CT-Guided Percutaneous Transthoracic Core Needle Biopsy: Retrospective Evaluation Among 17 Thoracic Imaging Fellows at a Tertiary Referral Hospital.
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.26346.
    

    >> Share

    
    
58. DENNIE C, Dyer D, Goo JM, Revel MP, et al
    The Global Reading Room: A Likely Infectious Abnormality on Lung Cancer Screening CT.
    AJR Am J Roentgenol. 2021 Aug 4. doi: 10.2214/AJR.21.26617.
    

    >> Share

    
    July 2021
59. NAGANO H, Takumi K, Nakajo M, Fukukura Y, et al
    Dual-Energy CT-Derived Electron Density for Diagnosing Metastatic Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: Comparison With Conventional CT and FDG PET/CT Findings.
    AJR Am J Roentgenol. 2021 Jul 28. doi: 10.2214/AJR.21.26208.
    

    >> Share

    
    
60. THAPALIYA S, Gilligan LA, Brady SL, Anton CG, et al
    Comparison of 0.3-mSv CT to Standard-Dose CT for Detection of Lung Nodules in Children and Young Adults With Cancer.
    AJR Am J Roentgenol. 2021 Jul 7. doi: 10.2214/AJR.21.26183.
    

    >> Share

    
    June 2021
61. TSUCHIYA K
    Editorial Comment: New Insights Into the MRI Diagnosis of Brain Metastasis From Lung Cancer.
    AJR Am J Roentgenol. 2021 Jun 2. doi: 10.2214/AJR.21.26288.
    

    >> Share

    
    
62. CHELALA L, Hossain R, Kazerooni EA, Christensen JD, et al
    Lung-RADS Version 1.1: Challenges and a Look Ahead, From the AJR Special Series on Radiology Reporting and Data Systems.
    AJR Am J Roentgenol. 2021;216:1411-1422.
    

    >> Share

    
    
63. ARAUJO-FILHO JAB, Halpenny D, McQuade C, Puthoff G, et al
    Management of Pulmonary Nodules in Oncologic Patients: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2021;216:1423-1431.
    

    >> Share

    
    May 2021
64. KIM M, Suh CH, Lee SM, Park JE, et al
    Development of Brain Metastases in Patients With Non-Small Cell Lung Cancer and No Brain Metastases at Initial Staging Evaluation: Cumulative Incidence and Risk Factor Analysis.
    AJR Am J Roentgenol. 2021 May 26. doi: 10.2214/AJR.21.25787.
    

    >> Share

    
    
65. BRUZZI JF
    Editorial Comment: Metabolic Tumor Volume on FDG PET/CT for Predicting Lymphovascular Invasion of Lung Cancer-Proceed With Caution.
    AJR Am J Roentgenol. 2021 May 19. doi: 10.2214/AJR.21.26193.
    

    >> Share

    
    
66. KOO CW
    Editorial Comment: Lobectomy Versus Sublobar Resection-How Preoperative CT Features Can Tell You How Much to Resect in Stage IA Non-Small Cell Lung Cancer.
    AJR Am J Roentgenol. 2021 May 19. doi: 10.2214/AJR.21.26175.
    

    >> Share

    
    
67. LI C, Tian Y, Shen Y, Wen B, et al
    Utility of Volumetric Metabolic Parameters on Preoperative FDG PET/CT for Predicting Tumor Lymphovascular Invasion in Non-Small Cell Lung Cancer.
    AJR Am J Roentgenol. 2021 May 12. doi: 10.2214/AJR.21.25814.
    

    >> Share

    
    
68. CHOE J, Kim MY, Yun JK, Lee GD, et al
    Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.
    AJR Am J Roentgenol. 2021 May 12. doi: 10.2214/AJR.21.25618.
    

    >> Share

    
    
69. HAAS BM
    Editorial Comment: Report Extent of Consolidation and Pulmonary Artery Diameter in Patients With Interstitial Lung Disease Who Are Undergoing an Initial Evaluation of Lung Cancer.
    AJR Am J Roentgenol. 2021 May 5. doi: 10.2214/AJR.21.26099.
    

    >> Share

    
    April 2021
70. OZAWA Y, Shibamoto Y, Hiroshima M, Nakagawa M, et al
    Preoperative CT Findings for Predicting Acute Exacerbation of Interstitial Pneumonia After Lung Cancer Surgery: A Multicenter Case-Control Study.
    AJR Am J Roentgenol. 2021 Apr 14. doi: 10.2214/AJR.21.25499.
    

    >> Share

    
    
71. GAN JM, Kikano EG, Smith DA, Bui MT, et al
    Role of Key Guidelines in an Era of Precision Oncology: A Primer for the Radiologist.
    AJR Am J Roentgenol. 2021;216:1112-1125.
    

    >> Share

    
    March 2021
72. CHO JY, Winant AJ, Sohn JH, Vargas SO, et al
    CT Features of Benign Intrapulmonary Lymph Nodes in Pediatric Patients With Known Extrapulmonary Solid Malignancy.
    AJR Am J Roentgenol. 2021 Mar 17:1-6. doi: 10.2214/AJR.20.23363.
    

    >> Share

    
    December 2020
73. SMITH DA, Radzinsky E, Tirumani SH, Guler E, et al
    Findings on Chest CT Performed in the Emergency Department in Patients on Immune Checkpoint Inhibitor Therapy: Single-Institution 8-Year Experience in 136 Patients.
    AJR Am J Roentgenol. 2020 Dec 9. doi: 10.2214/AJR.20.24758.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share